Literature DB >> 33956484

Optimized scan delay for late hepatic arterial or pancreatic parenchymal phase in dynamic contrast-enhanced computed tomography with bolus-tracking method.

Yoshifumi Noda1, Nobuyuki Kawai1, Takuma Ishihara2, Yoshiki Tsuboi2, Tetsuro Kaga1, Toshiharu Miyoshi3, Fuminori Hyodo4, Masayuki Matsuo1.   

Abstract

OBJECTIVES: To determine the optimal scan delay corresponding to individual hemodynamic status for pancreatic parenchymal phase in dynamic contrast-enhanced CT of the abdomen.
METHODS: One hundred and fourteen patients were included in this retrospective study (69 males and 45 females; mean age, 67.9 ± 12.1 years; range, 39-87 years). These patients underwent abdominal dynamic contrast-enhanced CT between November 2019 and May 2020. We calculated and recorded the time from contrast material injection to the bolus-tracking trigger of 100 Hounsfield unit (HU) at the abdominal aorta (s) (TimeTRIG) and scan delay from the bolus-tracking trigger to the initiation of pancreatic parenchymal phase scanning (s) (TimeSD). The scan delay ratio (SDR) was defined by dividing the TimeSD by TimeTRIG. Non-linear regression analysis was conducted to assess the association between CT number of the pancreas and SDR and to reveal the optimal SDR, which was ≥120 HU in pancreatic parenchyma.
RESULTS: The non-linear regression analysis showed a significant association between CT number of the pancreas and the SDR (p < 0.001). The mean TimeTRIG and TimeSD were 16.1 s and 16.8 s, respectively. The SDR to peak enhancement of the pancreas (123.5 HU) was 1.00. An SDR between 0.89 and 1.18 shows an appropriate enhancement of the pancreas (≥120 HU).
CONCLUSION: The CT number of the pancreas peaked at an SDR of 1.00, which means TimeSD should be approximately the same as TimeTRIG to obtain appropriate pancreatic parenchymal phase images in dynamic contrast-enhanced CT with bolus-tracking method. ADVANCES IN KNOWLEDGE: The hemodynamic state is different in each patient; therefore, scan delay from the bolus-tracking trigger should also vary based on the time from contrast material injection to the bolus-tracking trigger. This is necessary to obtain appropriate late hepatic arterial or pancreatic parenchymal phase images in dynamic contrast-enhanced CT of the abdomen.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33956484      PMCID: PMC8173674          DOI: 10.1259/bjr.20210315

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  24 in total

1.  Optimized enhancement in helical CT: experiences with a real-time bolus tracking system in 628 patients.

Authors:  J Kirchner; R Kickuth; U Laufer; M Noack; D Liermann
Journal:  Clin Radiol       Date:  2000-05       Impact factor: 2.350

2.  Sixty-four-multidetector-row computed tomography angiography with bolus tracking to time arterial-phase imaging in healthy liver: is there a correlation between quantitative and qualitative scores?

Authors:  Marcello Osimani; Marco Rengo; Pasquale Paolantonio; Riccardo Ferrari; Carlo Nicola De Cecco; Davide Bellini; Marco Maria Maceroni; Andrea Laghi
Journal:  J Comput Assist Tomogr       Date:  2010 Nov-Dec       Impact factor: 1.826

3.  Optimizing scan timing of hepatic arterial phase by physiologic pharmacokinetic analysis in bolus-tracking technique by multi-detector row computed tomography.

Authors:  Isao Yamaguchi; Eiji Kidoya; Masayuki Suzuki; Hirohiko Kimura
Journal:  Radiol Phys Technol       Date:  2010-09-25

Review 4.  Scan and contrast administration principles of MDCT.

Authors:  Kyongtae Ty Bae; Jay P Heiken
Journal:  Eur Radiol       Date:  2005-12       Impact factor: 5.315

5.  Optimizing scan delays of fixed duration contrast injection in contrast-enhanced biphasic multidetector-row CT for the liver and the detection of hypervascular hepatocellular carcinoma.

Authors:  Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Hironori Nishibori; Hiroki Kato; Ryujiro Yokoyama; Toshiharu Miyoshi; Hiroaki Hoshi; Minoru Onozuka; Noriyuki Moriyama
Journal:  J Comput Assist Tomogr       Date:  2005 Mar-Apr       Impact factor: 1.826

6.  MDCT of the pancreas: optimizing scanning delay with a bolus-tracking technique for pancreatic, peripancreatic vascular, and hepatic contrast enhancement.

Authors:  Hiroshi Kondo; Masayuki Kanematsu; Satoshi Goshima; Toshiharu Miyoshi; Yoshimune Shiratori; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  AJR Am J Roentgenol       Date:  2007-03       Impact factor: 3.959

7.  Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT.

Authors:  Joel G Fletcher; Maurits J Wiersema; Michael A Farrell; Jeff L Fidler; Lawrence J Burgart; Takashi Koyama; C Daniel Johnson; David H Stephens; Ellen M Ward; W Scott Harmsen
Journal:  Radiology       Date:  2003-10       Impact factor: 11.105

8.  Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.

Authors:  Sungeun Park; Ijin Joo; Dong Ho Lee; Jae Seok Bae; Jeongin Yoo; Se Woo Kim; Jeong Min Lee
Journal:  Radiology       Date:  2020-07-21       Impact factor: 11.105

9.  Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures.

Authors:  D S Lu; S Vedantham; R M Krasny; B Kadell; W L Berger; H A Reber
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

10.  CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.

Authors:  Jong Keon Jang; Jae Ho Byun; Ji Hun Kang; Jung Hee Son; Jin Hee Kim; Seung Soo Lee; Hyoung Jung Kim; Changhoon Yoo; Kyu-Pyo Kim; Seung-Mo Hong; Dong-Wan Seo; Song Cheol Kim; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2020-08-26       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.